BioHealth News
ATCC Announces New Award from BARDA to Provide Centralized Storage and Bioprocessing Services for Project NextGen
Project NextGen is a $5 billion initiative to develop next-generation medical countermeasures, including vaccines and therapeutics, to enhance preparedness for future COVID-19 strains and…
Read More
MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR’s TCR-T Cell Pipeline
Lion TCR to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to develop and scale TCR-T cell therapies for solid tumors and viral-related diseases.…
Read More
Rockville’s GlycoMimetics Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1a Healthy Volunteer Study of GMI-1687
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced positive…
Read More
NIH: Artificial Intelligence and Your Health – How Computers are Helping Medicine
There’s a lot of talk about artificial intelligence, or AI, these days. AI is everywhere—from virtual assistants to facial recognition software. The technology is…
Read More
TEDCO Invests in PediaMetrix
Maryland biotechnology company promotes improved patient outcomes for infants with body deformities COLUMBIA, Md. (January 3, 2024) – TEDCO, Maryland’s economic engine for technology companies, announced…
Read More
Sonavex Announces Successful Clinical Study of EchoMark & EchoSure and Initiation of the MAFASA Randomized Controlled Trial
FDA IDE approval of Sonavex's randomized trial comes months after meeting the endpoint of its first clinical study BALTIMORE, Jan. 2, 2024 /PRNewswire-PRWeb/ -- Sonavex, Inc., a…
Read More
NSF announces first-ever Accelerating Research Translation awards to empower academic institutions to speed and scale translational research (GMU a winner)
The U.S. National Science Foundation today announced the first-ever Accelerating Research Translation (ART) investment — more than $100 million to 18 teams at academic…
Read More
Advancing Hope: Solaxa’s Quest to Treat Cerebellar Ataxias on the BioTalk Podcast
In this episode of BioTalk with Rich Bendis, we’re joined by three guests from Solaxa: CEO & Founder Christian Walker, Chief Operating Officer Luis…
Read More